l9n/ Oregon

2019 Regular Session

House Bill 3093

Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services total cost of patient assistance programs and information on financial assistance provided to pharmacies, government agencies and advocacy organizations.

Did not become law. It stopped in the House of Representatives's Health Care Committee on June 30, 2019. The 2019 session has ended.

What it does

The synopsis the Legislative Assembly published with the bill.

Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services total cost of patient assistance programs and information on financial assistance provided to pharmacies, government agencies and advocacy organizations. Excludes proprietary information from disclosure on department's website. Requires state-sponsored programs that use pharmacy benefit managers to use fee-only pharmacy benefit managers. Requires insurers to post specified information regarding formulary, tiers and costs to insurer's website. Requires 60-day advance notice to enrollees adversely affected by change in formulary. Requires insurer and allows pharmacy to notify insured that if cash price for drug is less than insured's cost-share for drug, insured may pay cash price and expense must be counted toward deductible or out-of-pocket maximum. Requires hospitals and other medical providers to disclose in patient billing information regarding mark-up on price of drug. Also requires billing to disclose price of drug charged to specified state agencies and insurers. Requires specified state agencies to report to Legislative Assembly on high-cost drugs. Requires Oregon Health Authority to refer to Pharmacy and Therapeutics Committee any drug exceeding specified cost. Requires patient advocacy organization with budget exceeding $50,000 that has registered lobbyist in this state to report to Oregon Government Ethics Commission and Oregon Health Authority specified information regarding funding received from participants in pharmaceutical supply chain. Requires pharmacy benefit managers to report to Department of Consumer and Business Services and plan sponsors specified information regarding rebates, reimbursements, fees and incentives paid for drugs by manufacturers, insurers and pharmacies. Requires drug advertisement to disclose wholesale price of drug.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

14 co-sponsors

Janelle Bynum, Brian Clem, Lynn Findley, Ken Helm, Alissa Keny-Guyer, Pam Marsh, Mark Meek, Courtney Neron Misslin, Rob Nosse, E. Werner Reschke, Andrea Salinas, Gregory Smith, Janeen Sollman, Marty Wilde

In the Senate

21 co-sponsors

Cliff Bentz, Brian Boquist, Ginny Burdick, Peter Courtney, Michael Dembrow, Shemia Fagan, Lew Frederick, Sara Gelser Blouin, Jeff Golden, Bill Hansell, Mark Hass, Dallas Heard, Betsy Johnson, James Manning Jr., Laurie Monnes Anderson, Floyd Prozanski, Chuck Riley, Arnie Roblan, Kathleen Taylor, Rob Wagner, Jackie Winters

Its course

February 26 to June 30, 2019, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action3 actions on 3 days

In the House of RepresentativesFeb 26 to Jun 30 · stopped124 days

Waiting for a committeeFeb 26 to Mar 13 days

Health CareMar 1 to Jun 30 · stopped121 days

Text

Each version as the Legislative Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.

In the House of Representatives Feb 26 – Jun 30

  1. Feb 26Introduced
  2. Mar 1Sent to Health Care
  3. Jun 30Died when the session ended
All 3 actions, as published
  1. Feb 26First reading. Referred to Speaker's desk.House of Representatives
  2. Mar 1Referred to Health Care with subsequent referral to Ways and Means.House of Representatives
  3. Jun 30In committee upon adjournment.House of Representatives